Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Filip S. Ekholm"'
Autor:
Jelena Matović, Juulia Järvinen, Iris K. Sokka, Surachet Imlimthan, Olli Aitio, Mirkka Sarparanta, Jarkko Rautio, Filip S. Ekholm
Publikováno v:
Molecules, Vol 29, Iss 17, p 4263 (2024)
Boron Neutron Capture Therapy (BNCT) is a cancer treatment which combines tumor-selective boron delivery agents with thermal neutrons in order to selectively eradicate cancer cells. In this work, we focus on the early-stage development of carbohydrat
Externí odkaz:
https://doaj.org/article/9c47b19bd5b341ce9b2e8aff4ce2ab60
Autor:
Jelena Matović, Katayun Bahrami, Philipp Stockmann, Iris K. Sokka, You Cheng Khng, Mirkka Sarparanta, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S. Ekholm
Publikováno v:
Molecular Pharmaceutics.
Publikováno v:
Nano Letters. 21:7676-7683
In healthy eyes, the tear film lipid layer (TFLL) is considered to act as an evaporation resistant barrier, which prevents eyes from drying. Seeking to understand the mechanisms behind the evaporation resistance of the TFLL, we studied mixtures of li
Autor:
Mirkka Sarparanta, Surachet Imlimthan, Iris Katariina Sokka, Filip S. Ekholm, Mikael P. Johansson, Hannu Maaheimo
Publikováno v:
Sokka, I K, Imlimthan, S, Sarparanta, M, Maaheimo, H, Johansson, M P & Ekholm, F S 2021, ' Halogenation at the phenylalanine residue of monomethyl auristatin f leads to a favorable cis/ trans equilibrium and retained cytotoxicity ', Molecular Pharmaceutics, vol. 18, no. 8, pp. 3125-3131 . https://doi.org/10.1021/acs.molpharmaceut.1c00342
Molecular Pharmaceutics
Molecular Pharmaceutics
Halogenation can be utilized for the purposes of labeling and molecular imaging, providing a means to, e.g., follow drug distribution in an organism through positron emission tomography (PET) or study the molecular recognition events unfolding by nuc
Autor:
Jelena Matović, Juulia Järvinen, Iris K. Sokka, Philipp Stockmann, Martin Kellert, Surachet Imlimthan, Mirkka Sarparanta, Mikael P. Johansson, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S. Ekholm
Glucose-and sodium-dependent glucose transporters (GLUTs and SGLTs) play vital roles in human biology. Of the 14 GLUTs and 12 SGLTs, the GLUT1 transporter has gained t h e most widespread recognition because GLUT1 is overexpressed in several cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f817c06505986eb7aff16321321477a
http://hdl.handle.net/10138/350550
http://hdl.handle.net/10138/350550
Autor:
Jelena, Matović, Juulia, Järvinen, Iris K, Sokka, Philipp, Stockmann, Martin, Kellert, Surachet, Imlimthan, Mirkka, Sarparanta, Mikael P, Johansson, Evamarie, Hey-Hawkins, Jarkko, Rautio, Filip S, Ekholm
Publikováno v:
ACS omega. 7(34)
Glucose- and sodium-dependent glucose transporters (GLUTs and SGLTs) play vital roles in human biology. Of the 14 GLUTs and 12 SGLTs, the GLUT1 transporter has gained the most widespread recognition because GLUT1 is overexpressed in several cancers a
Publikováno v:
The Journal of Organic Chemistry
Correction: 10.1021/acs.joc.1c02513. The tear film lipid layer (TFLL) that covers the ocular surface contains several unique lipid classes, including O-acyl-omega-hydroxy fatty acids, type I-St diesters, and type II diesters. While the TFLL represent
Autor:
Filip S. Ekholm, Suvi-Katriina Ruokonen, Marina Redón, Virve Pitkänen, Anja Vilkman, Juhani Saarinen, Jari Helin, Tero Satomaa, Susanne K. Wiedmer
Publikováno v:
Separations, Vol 6, Iss 1, p 1 (2018)
Antibody-drug conjugates (ADCs) are promising state-of-the-art biopharmaceutical drugs for selective drug-delivery applications and the treatment of diseases such as cancer. The idea behind the ADC technology is remarkable as it combines the highly s
Externí odkaz:
https://doaj.org/article/ce3bcce3ae8246aabae69be02a0c9af4
Publikováno v:
Nano letters. 21(18)
In healthy eyes, the tear film lipid layer (TFLL) is considered to act as an evaporation resistant barrier, which prevents eyes from drying. Seeking to understand the mechanisms behind the evaporation resistance of the TFLL, we studied mixtures of li
Publikováno v:
Molecular Pharmaceutics
Monomethyl auristatin E and monomethyl auristatin F are widely used cytotoxic agents in antibody-drug conjugates (ADCs), a group of promising cancer drugs. The ADCs specifically target cancer cells, releasing the auristatins inside, which results in